L-carnitine affects osteoblast differentiation in NIH3T3 fibroblasts by the IGF-1/PI3K/Akt signalling pathway

BioScience Trends

Volumn 9, Issue 1, 2015, Pages 42-48

  Ge, Pinglan ^a,b   Cui, Yazhou ^a   Liu, Fang ^a,b   Luan, Jing ^a   Zhou, Xiaoyan ^a   Han, Jinxiang ^a  

^a BEIJING HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Ectopic calcification; Fibroblast; IGF 1 PI3K Akt; L carnitine; Osteoblastic differentiation; Proliferation

Indexed keywords

ANIMALIA;

CALCIUM; CARNITINE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C;

3T3 CELL LINE; ANIMAL; CALCINOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; METABOLISM; MOUSE; OSTEOBLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CALCINOSIS; CALCIUM; CARNITINE; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLASTS; INSULIN-LIKE GROWTH FACTOR I; MICE; NIH 3T3 CELLS; OSTEOBLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84924907253     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2015.01000     Document Type: Article

References (46)

1. Cotran RS, Kumare V, Robbins SL. Cellular injury and cellular death. In: Pathological Basis of Disease. 5th ed., WB Saunders Press, Philadelphia, PA, USA, 1994; pp. 1-35.
2. Uitto J, Li Q, Jiang Q. Pseudoxanthoma elasticum: Molecular genetics and putative pathomechanisms. J Invest Dermatol. 2010; 130:66.
3. Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A. 2000; 97:6001-6006.
4. Le Saux O, Urban Z, Tschuch C, Csiszar K, Bacchelli B, Quaglino D, Pasquali-Ronchetti I, Pope FM, Richards A, Terry S, Bercovitch L, de Paepe A, Boyd CD. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet. 2000; 25:223-227.
5. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, Swart J, Kool M, van Soest S, Baas F, ten Brink JB, de Jong PT. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet. 2000; 25:228-231.
6. Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT, van Kuppevelt TH, Levelt CN, de Wolf A, Loves WJ, Scheper RJ, Peek R, Bergen AA. Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet. 2005; 14:1763-1773.
7. Klement JF, Matsuzaki Y, Jiang QJ, Terlizzi J, Choi HY, Fujimoto N, Li K, Pulkkinen L, Birk DE, Sundberg JP, Uitto J. Targeted ablation of the Abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol. 2005; 25:8299-8310.
8. Friedenstein AY. Induction of bone tissue by transitional epithelium. Clin Orthop Relat Res. 1968; 59:21-37.
9. Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science. 2000; 289:1501-1504.
10. Rutherford RB, Moalli M, Franceschi RT, Wang D, Gu K, Krebsbach PH. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 2002; 8:441-52.
11. Reddi AH, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci U S A. 1972; 69:1601-1605.
12. Zhang J, Khvorostov I, Hong JS, et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 2011; 30: 4860-4873.
13. Borum PR. Regulation of carnitine concentration in plasma. In: Carnitine biosynthesis, metabolism and functions (Frenkel RA, McGarry JD, eds.). Academic Press, New York, USA, 1980; pp. 115-126.
14. Adamek G, Felix R, Guenther HL, Fleisch H. Fatty acid oxidation in bone tissue and bone cells in culture. Biochem J. 1987; 242:129-137.
15. Colucci S, Mori G, Vaira S, Brunetti G, Greco G, Mancini L, Simone GM, Sardelli F, Koverech A, Zallone A, Grano M. L-Carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int. 2005; 6:458-465.
16. Xie H, Tang SY, Li H, Luo XH, Yuan LQ, Wang D, Liao EY. L-Carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells. Amino Acids. 2008; 2:419-423.
17. Chiu KM, Keller ET, Crenshaw TD, Gravenstein S. Carnitine and dehydroepiandrosterone sulphate induced protein synthesis in porcine osteoblast-like cells. Calcif Tissue Int. 1999; 64:527-533.
18. Mohan S, Baylink DJ. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res. 1996; 45(Suppl 1):59-62.
19. Jonsson KB, Ljunghall S, Karlström O, Johansson AG, Mallmin H, Ljunggren O. Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human. Biosci Rep. 1993; 13:297-302.
20. Gangji V, Rydziel S, Gabbitas B, Canalis E. Insulin-like growth factor II promoter expression in cultured rodent osteoblasts and adult rat bone. Endocrinology. 1998; 139:2287-2292.
21. Langdahl BL, Kassem M, Møller MK, Eriksen EF. The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone. Eur J Clin Invest. 1998; 28:176-183.
22. Heo YR, Kang CW, Cha YS. L-Carnitine changes the levels of insulin-like growth factors (IGFs) and IGF binding proteins in streptozotocin-induced diabetic rat. J Nutr Sci Vitaminol (Tokyo). 2001; 47:329-334.
23. Kita K, Kato S, Amanyaman M, Okumura J, Yokota H. Dietary L-carnitine increases plasma insulin-like growth factor-I concentration in chicks fed a diet with adequate dietary protein level. Br Poult Sci. 2002; 43:117-121.
24. Doberenz J, Birkenfeld C, Kluge H, Eder K. Effects of L-carnitine supplementation in pregnant sows on plasma concentrations of insulin-like growth factors, various hormones and metabolites and chorion characteristics. J Anim Physiol Anim Nutr (Berl). 2006; 90:487-499.
25. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002; 296:1655-1657.
26. Hofler A, Nichols T, Grant S, Lingardo L, Esposito EA, Gridley S, Murphy ST, Kath JC, Cronin CN, Kraus M, Alton G, Xie Z, Sutton S, Gehring M, Ermolieff J. Study of the PDK1/AKT signaling pathway using selective PDK1 inhibitors, HCS, and enhanced biochemical assays. Anal Biochem. 2011; 414:179-186.
27. Chen LL, Huang M, Tan JY, Chen XT, Lei LH, Wu YM, Zhang DY. PI3K/AKT pathway involvement in the osteogenic effects of osteoclast culture supernatants on preosteoblast cells. Tissue Eng Part A. 2013; 19:2226-2232.
28. Suzuki E, Ochiai-Shino H, Aoki H, Onodera S, Saito A, Saito A, Azuma T. Akt activation is required for TGF-ß1-Induced osteoblast differentiation of MC3T3-E1 preosteoblasts. PLoS One. 2014; 9:e112566.
29. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87:e10-17.
30. Castiglioni S, Casati S, Ottria R, Ciuffredav P, Maier JA. N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells. Anticancer Agents Med Chem. 2013; 13:672-678.
31. Yamakawa K, Iwasaki H, Masuda I, Ohjimi Y, Honda I, Saeki K, Zhang J, Shono E, Natio M, Kikuchi M. The utility alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol. 2003; 30: 1032-1035.
32. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem. 1995; 270:9420-9428.
33. Hernandez L, Park KH, Cai SQ, Qin L, Partridge N, Sesti F. The antiproliferative role of ERG K+ channels in rat osteoblastic cells. Cell Biochem Biophys. 2007; 47:199-208.
34. Zhang YY, Cui YZ, Luan J, Zhou XY, Zhang GL, Han JX. Platelet-derived growth factor receptor kinase inhibitor AG-1295 promotes osteoblast differentiation in MC3T3-E1 cells via the Erk pathway. Biosci Trends. 2012; 6:130-135.
35. Rutsch F, Nitschke Y, Terkeltaub R. Genetics in arterial calcification: Pieces of a puzzle and cogs in a wheel. Circ Res. 2011; 109:578-592.
36. Giachelli CM. Ectopic calcification: Gathering hard facts about soft tissue mineralization. Am J Pathol. 1999; 154:671-675.
37. Beresford JN, Graves SE, Smoothy CA. Formation of mineralized nodules by bone derived cells in vitro: A model of bone formation? Am J Med Genet. 1993; 45:163-178.
38. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 1990; 4:3111-3123.
39. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TL, Centrella M. CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem. 1998; 69:353-363.
40. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2010; 339:189-195.
41. Patti A, Gennari L, Merlotti D, Dotta F, Nuti R. Endocrine actions of osteocalcin. Int J Endocrinol. 2013; 2013:846480.
42. Weinreb M, Shinar D, Rodan GA. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res. 1990; 5:831-842.
43. Keller J, Couturier A, Haferkamp M, Most E, Eder K. Supplementation of carnitine leads to an activation of the IGF-1/PI3K/Akt signaling pathway and down regulates the E3 ligase MuRF1 in skeletal muscle of rats. Nutr Metab (Lond). 2013; 10:28.
44. Colucci S, Mori G, Vaira S, Brunetti G, Greco G, Mancini L, Simone GM, Sardelli F, Koverech A, Zallone A, Grano M. L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation of adult stem cells. Calcif Tissue Int. 2005; 76:458-465.
45. Lu Q, Zhang Y, Elisseef JH. Carnitine and accetylcarnitine modulate mesenchymal differentiation of adult stem cells. J Tissue Eng Regen Med. 2013; 1747. (doi: 10.1002/term.1747)
46. Xie H, Yang B, Zhou XM, Song FL, Li JM, Zhou K, Hu W, Peng YQ, Tang SY, Yuan LQ, Xiong SY, Liao XB. L-carnitine and taurine synergistically inhibit the proliferation and osteoblastic differentiation of vascular smooth muscle cells. Acta Pharmacol Sin. 2010; 31:289-296.